Sun Pharmaceutical Industries Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

239.93

239.93

239.93

239.93

239.93

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

23,454.47

23,508.43

24,348.02

24,800.23

24,156.29

Loan funds

Secured loans

11,046.61

7,592.67

4,868.71

6,485.54

5,744.96

Unsecured loans

-

-

-

-

-

Total

34,741.01

31,341.03

29,456.66

31,525.70

30,141.18

Uses of funds

Fixed assets

Gross block

11,933.29

12,491.88

12,991.59

8,025.93

7,516.61

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

4,196.55

3,780.21

3,278.81

2,781.57

2,287.87

Net block

7,736.74

8,711.67

9,712.78

5,244.36

5,228.74

Capital work-in-progress

766.11

852.91

828.64

762.79

596.61

Investments

12,429.97

12,616.40

15,548.87

16,998.68

17,361.72

Net current assets

Current assets, loans & advances

20,131.97

18,806.51

14,675.19

15,993.00

15,223.26

Less : current liabilities & provisions

6,323.78

9,646.46

11,308.82

7,473.13

8,269.15

Total net current assets

13,808.19

9,160.05

3,366.37

8,519.87

6,954.11

Miscellaneous expenses not written

-

-

-

-

-

Total

34,741.01

31,341.03

29,456.66

31,525.70

30,141.18

Notes:

Book value of unquoted investments

94.00

200.26

193.04

31.55

392.75

Market value of quoted investments

6.33

-

-

9.02

8.16

Contingent liabilities

2,013.74

4,309.60

3,811.82

3,564.25

3,863.62

Number of equity sharesoutstanding (Lacs)

23993.35

23993.35

23993.35

23993.35

23993.35